NCT02853864View on ClinicalTrials.gov

Influence of Gender on Interaction of Propofol and Dexmedetomidine

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Anesthesia
Interventions
DRUG

0.0 ng/ml Dexmedetomidine

Dexmedetomidine target plasma concentration is 0.0 ng/ml

DRUG

0.4 ng/ml Dexmedetomidine

Dexmedetomidine target plasma concentration is 0.4 ng/ml

DRUG

0.6 ng/ml Dexmedetomidine

Dexmedetomidine target plasma concentration is 0.6 ng/ml

DRUG

0.8 ng/ml Dexmedetomidine

Dexmedetomidine target plasma concentration is 0.8 ng/ml

DRUG

Propofol

The propofol infusion was started to provide an effect-site concentration of 1.0 ug/ml, and increased by 0.2 ug/ml until loss of consciousness

Trial Locations (1)

510010

Guangzhou Military Region General Hospital, Department of Anesthesiology, Guangzhou

All Listed Sponsors
lead

Guangzhou General Hospital of Guangzhou Military Command

OTHER

NCT02853864 - Influence of Gender on Interaction of Propofol and Dexmedetomidine | Biotech Hunter | Biotech Hunter